Title

Combined BH3 and Metabolic Profiling as a Method to Define Therapeutic Response and Resistance in Grade IB Astrocytomas

Publication Date

11-2015

Presented At:

Society for Neuro-Oncology Annual Scientific Meeting

Content Type

Presentation

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS